Unichem Laboratories Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Unichem Laboratories Ltd. from all sources in a single place.

Load latest

Unichem Laboratories Ltd.

28 Apr 2022

586.35

-0.37%

Corp. Note

UNICHEM LABORATORIES LTD. - 506690 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayUNICHEM LABORATORIES LTD. 2CINL99999MH1962PLC012451 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 115.00 4Highest Credit Rating during the previous FY A- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pradeep Bhandari Designation: Head Legal and CS EmailId: pradeep.bhandari@unichemlabs.com Name of the Chief Financial Officer: Sandip Ghume Designation: Deputy CFO EmailId: sandip.ghume@unichemlabs.com Date: 28/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Unichem Laboratories Ltd.

14 Apr 2022, 05:11PM

586.35

-0.37%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LODR) REGULATIONS, 2015 …

BSE India

COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF THE SEBI (LODR) REGULATIONS, 2015 FOR THE YEAR ENDED 31.03.2022

pdf

Unichem Laboratories Ltd.

11 Apr 2022

586.35

-0.37%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2022

pdf

Unichem Laboratories Ltd.

11 Apr 2022

586.35

-0.37%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Compliance Certificate For The Period April 1, 2021 To March …

BSE India

As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period April 1, 2021 to March 31, 2022 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share Transfer Agent in Category-I with the Securities and Exchange Board of India vide Registration Number: INR000004058.

pdf

Unichem Laboratories Ltd.

11 Apr 2022

586.35

-0.37%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Statement Of Investor Complaints For The Quarter Ended March 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pradeep BhandariDesignation :- Company Secretary and Compliance Officer

Unichem Laboratories Ltd.

31 Mar 2022

586.35

-0.37%

SAST

UNICHEM LABORATORIES LTD. - 506690 - Closure of Trading Window

BSE India

Notice of trading window close.

pdf

Unichem Laboratories Ltd.

16 Mar 2022

586.35

-0.37%

Unichem Laboratories gets USFDA approval for generic Nebivolol tablets

Business Standard

Unichem Laboratories on Wednesday said it has received approval from the US health regulator to market its generic version of Nebivolol tablets indicated for the treatment of hypertension

Unichem Laboratories Ltd. is trading below all available SMAs

Unichem Laboratories gets USFDA nod for generic Nebivolol tablets

Moneycontrol | 16 Mar 2022 1 more

Unichem Laboratories Ltd.

16 Mar 2022

586.35

-0.37%

Company Update

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg.

pdf

Unichem Laboratories Ltd.

15 Mar 2022, 01:23PM

586.35

-0.37%

Corp. Note

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we furnish herewith the intimation about the loss / misplacement of Share Certificate(s), as received from Link Intime India Pvt Ltd, the Registrar & Share Transfer Agents of Company.

pdf